National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 50680-50681 [2014-20058]

Download as PDF 50680 Federal Register / Vol. 79, No. 164 / Monday, August 25, 2014 / Notices emcdonald on DSK67QTVN1PROD with NOTICES status/Pages/status.aspx. The NIH is required by the BPCA to update the priority list every three years. This publication serves as an update to the BPCA priority list of needs in pediatric therapeutics. The Obstetric and Pediatric Pharmacology and Therapeutics Branch of the NICHD developed a prioritization process for the determination of the needs in pediatric therapeutics. There are two main phases in this process. Phase I of the prioritization process entails identifying therapeutic areas, which are general categories of conditions, diseases, settings of care, or populations with multiple therapeutic needs. The NICHD solicits input from experts in the pediatric research, general pediatric and subspecialty care, and patient advocacy groups to determine these therapeutic areas that need further study. At the beginning of every year, the NICHD revisits the current list of needs in pediatric therapeutics, prioritizes three therapeutic areas of interest for that calendar year, and develops working groups in the prioritized areas. Recommendations from the therapeutic area working groups are then presented to the NICHD and the FDA at the end of the calendar year at the Institute’s annual BPCA meeting. Previous meeting minutes can be found on the BPCA Web site: https://bpca.nichd.nih.gov/prioritization/ meetings/Pages/index.aspx. Phase II of the prioritization process entails an extensive review and ranking of all nominations received based on key criteria for prioritization, such as relevance, label gaps, affected population, and feasibility. Please visit the BPCA Web site for more details: (https://bpca.nichd.nih.gov/ prioritization/priority_list/Pages/ priority_list.aspx). Below is an updated list of therapeutic areas and drugs that have been prioritized for study since the inception of the BPCA and a summary of the NICHD’s plans and progress in all of these areas to date. The NICHD welcomes input from the pediatric medical community on additional gaps in pediatric therapeutics for future consideration. All nominations should be submitted to Dr. Perdita TaylorZapata (contact information below). Priority List of Needs in Pediatric Therapeutics 2014 In accordance with the BPCA legislation, the list outlines priority needs in pediatric therapeutics for multiple therapeutic areas listed below. The complete list can be found on the BPCA Web site at the following address: https://bpca.nichd.nih.gov. VerDate Mar<15>2010 17:31 Aug 22, 2014 Jkt 232001 D Table 1: Infectious Disease Priorities D Table 2: Cardiovascular Disease Priorities D Table 3: Respiratory Disease Priorities D Table 4: Intensive Care Priorities D Table 5: Bio-Defense Research Priorities D Table 6: Pediatric Cancer Priorities D Table 7: Psychiatric Disorder Priorities D Table 8: Neurological Disease Priorities D Table 9: Neonatal Research Priorities D Table 10: Adolescent Research Priorities D Table 11: Hematologic Disease Priorities D Table 12: Endocrine Disease Priorities and Diseases With Limited Alternative Therapies D Table 13: Dermatologic Disease Priorities D Table 14: Gastrointestinal Disease Priorities D Table 15: Renal Disease Priorities D Table 16: Rheumatologic Disease Priorities D Table 17: Special Considerations We would like for you to save the date of December 10, 2014, for our annual BPCA stakeholders meeting. The meeting will be held at the Natcher Auditorium on the NIH campus in Bethesda, Maryland, and will be streamed live via videocast for all nonlocal attendees. FOR FURTHER INFORMATION CONTACT: Dr. Perdita Taylor-Zapata via email at taylorpe@mail.nih.gov; by phone at 301–496–9584; or by fax at 301–480– 2897. Dated: August 18, 2014. Francis S. Collins, Director, National Institutes of Health. [FR Doc. 2014–20156 Filed 8–22–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases Cancellation of Meeting Notice is hereby given of the cancellation of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel, September 10, 2014, 10:00 a.m. to September 10, 2014, 12:00 p.m., National Institutes of Health, 6700B Rockledge Drive, Room 3124, Bethesda, MD 20817 which was published in the Federal Register on August 15, 2014, 79FR48173. The Review Committee will not meet because the application was withdrawn. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Dated: August 19, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–20057 Filed 8–22–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Ancillary Studies to the NIDDK IBDGC. Date: October 16, 2014. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 756, 6707, Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–7682, campd@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases, Special Emphasis Panel, Small Grants for New Investigators to Promote Diversity. Date: October 30, 2014. Time: 12:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 402–7172, woynarowskab@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, E:\FR\FM\25AUN1.SGM 25AUN1 Federal Register / Vol. 79, No. 164 / Monday, August 25, 2014 / Notices Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: August 19, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–20058 Filed 8–22–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2014–0020; OMB No. 1660–0058] Agency Information Collection Activities: Submission for OMB Review; Comment Request Collection of Information Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: The Federal Emergency Management Agency (FEMA) will submit the information collection abstracted below to the Office of Management and Budget for review and clearance in accordance with the requirements of the Paperwork Reduction Act of 1995. The submission will describe the nature of the information collection, the categories of respondents, the estimated burden (i.e., the time, effort and resources used by respondents to respond) and cost, and the actual data collection instruments FEMA will use. DATES: Comments must be submitted on or before September 24, 2014. ADDRESSES: Submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the Desk Officer for the Department of Homeland Security, Federal Emergency Management Agency, and sent via electronic mail to oira.submission@ omb.eop.gov or faxed to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection should be made to Director, Records Management Division, 500 C Street, Washington, DC 20472–3100, facsimile number (202) 212–4701, or email address FEMA-Information-CollectionsManagement@dhs.gov. SUPPLEMENTARY INFORMATION: FEMA published a 60-day Federal Register emcdonald on DSK67QTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:31 Aug 22, 2014 Jkt 232001 Notice inviting public comments on May 28, 2014, 79 FR 30633. FEMA received one comment from one respondent. The commenter stated that government funds should not be used for pre-fire activities but rather homeowners should be responsible and take necessary steps to avoid fires. The commenter did approve of funds being used for cleanup. They also stated that government should be smaller. FEMA appreciates receiving this comment although the comment is not directly related to the cost and hour burden. If a grant is approved, the funds only pay for minimum pre-fire activities and these must be pre-approved in order to be eligible for funding. The funds used for pre-fire activities pay for prepositioning equipment and personnel so a fire can be more quickly mitigated and contained, which helps reduce government fire-fighting costs. Title: Fire Management Assistance Grant Program. Type of information collection: Extension, without change, of a currently approved information collection. OMB Number: 1660–0058. Form Titles and Numbers: FEMA Form 078–0–1, Request for Fire Management Assistance Declaration; FEMA Form 089–0–24, Request for Fire Management Sub-grant; FEMA Form 078–0–2, Principal Advisor’s Report. Abstract: The information collection is required to make grant eligibility determinations for the Fire Management Assistance Grant Program (FMAGP). These eligibility-based grants and subgrants provide assistance to any eligible State, Indian tribal government, or local government for the mitigation, management, and control of a fire on public or private forest land or grassland that is threatening such destruction as would constitute a major disaster. The data/information gathered in the forms is used to determine the severity of the threatening fire, current and forecast weather conditions, and associated factors related to the fire and its potential threat as a major disaster. Affected Public: State, local, or Tribal Government. Estimated Number of Respondents: 178. Estimated Total Annual Burden Hours: 811 hours. Estimated Cost: The estimated annual cost to respondents for the hour burden is $42,626.16. There are no annual costs to respondents’ operations and maintenance costs for technical services. There are no annual start-up or PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 50681 capital costs. The cost to the Federal Government is $532,814.00. Dated: August 14, 2014. Charlene D. Myrthil, Director, Records Management Division, Mission Support Bureau, Federal Emergency Management Agency, Department of Homeland Security. [FR Doc. 2014–20048 Filed 8–22–14; 8:45 am] BILLING CODE 9111–23–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2014–0019; OMB No. 1660–0103] Agency Information Collection Activities: Submission for OMB Review; Comment Request; Property Acquisition and Relocation for Open Space Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: The Federal Emergency Management Agency (FEMA) will submit the information collection abstracted below to the Office of Management and Budget for review and clearance in accordance with the requirements of the Paperwork Reduction Act of 1995. The submission will describe the nature of the information collection, the categories of respondents, the estimated burden (i.e., the time, effort and resources used by respondents to respond) and cost, and the actual data collection instruments FEMA will use. DATES: Comments must be submitted on or before September 24, 2014. ADDRESSES: Submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the Desk Officer for the Department of Homeland Security, Federal Emergency Management Agency, and sent via electronic mail to oira.submission@ omb.eop.gov or faxed to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection should be made to Director, Records Management Division, 500 C Street, Washington, DC 20472–3100, facsimile number (202) 212–4701, or email address FEMA-Information-CollectionsManagement@dhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: E:\FR\FM\25AUN1.SGM 25AUN1

Agencies

[Federal Register Volume 79, Number 164 (Monday, August 25, 2014)]
[Notices]
[Pages 50680-50681]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20058]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, Ancillary Studies to the 
NIDDK IBDGC.
    Date: October 16, 2014.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 756, 
6707, Democracy Boulevard, Bethesda, MD 20892-2542, 301-594-7682, 
campd@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases, Special Emphasis Panel, Small Grants for New 
Investigators to Promote Diversity.
    Date: October 30, 2014.
    Time: 12:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
402-7172, woynarowskab@niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes,

[[Page 50681]]

Endocrinology and Metabolic Research; 93.848, Digestive Diseases and 
Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology 
Research, National Institutes of Health, HHS)

    Dated: August 19, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-20058 Filed 8-22-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.